While neurological and psychiatric sequelae of COVID-19 have been reported, more data are needed to adequately assess the effects of COVID-19 on brain health.
For telemedicine to thrive in a postpandemic era, temporary rules regarding reimbursement and providers’ ability to fully care for the patient in any setting must be made permanent.
For the 12-month period ending in May 2020, the CDC reported 81,000 drug overdose deaths — the most ever recorded in a 12-month period in the United States. We interviewed Danielle F. Haley, MPH, PhD, assistant professor in the department of community health sciences at the Boston University School of Public Health about COVID-19 and the rates of substance abuse and overdose cases.
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
Sandhya Prashad, MD discusses how leveraging teletherapy has helped providers and patients troubleshoot common concerns around social distancing and has gotten many first-time patients in the “virtual” door.
Dr Ben Locwin spoke to Dr Joshua Gear about the impact COVID-19 has had on our collective mental health, how we’re doing with regard to coping with the crisis, substance abuse, and what’s next.
To learn more about the multifaceted effects of the COVID-19 pandemic on people living with HIV and how clinicians can best support these patients, we interviewed experts who have co-authored recently published papers pertaining to this topic.
“It has been over a year of constant trauma. It has been over a year of not sleeping.” How are healthcare workers managing their mental health during the COVID-19 pandemic?
We speak with Mildred Solomon, EdD, President of the Hastings Center and Professor of Global Health and Social Medicine at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, about the COVID-19 pandemic, health equity, and vaccine distribution.
We spoke to Carl V Hill, PhD, MPH, chief diversity, equity and inclusion officer of the Alzheimer’s Association about the results of the Alzheimer’s Association report, 2021 Alzheimer’s Disease Facts and Figures.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
Tori Rodriguez, MA, LPC, discusses chronic pain among patients with Parkinson disease and the breakdown of disease subtypes, classification, and pathophysiology.
The pandemic poses unprecedented challenges to the grieving process, setting the stage for more complex and prolonged reactions in those who have unfortunately lost loved ones. M. Katherine Shear, MD, Marion E. Kenworthy Professor of Psychiatry, Columbia University School of Social Work, Columbia University College of Physicians and Surgeons, New York, NY, and Director of the Center for Complicated Grief shares her insight into this subject.
With food insecurity on the rise in the United States, we interview two authors of a study on food insufficiency in the US and its impact on mental health.
Tracy Butler, MD, discusses the potential of leuprolide acetate for the treatment of Alzheimer disease in women also receiving the acetylcholinesterase inhibitor donepezil.
We interviewed Pamela Anne Nelson, DNP, PMHNP-BC, FNP-BC, who recently co-authored a paper regarding the role of primary care providers in suicide prevention during the pandemic.
To learn more about the overlapping crises of the opioid epidemic and the COVID-19 pandemic, Psychiatry Advisor interviewed pain specialist Paul J. Christo, MD, MBA, the Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital in Baltimore, Maryland.
Activities ranging from household tasks to outdoor exercises have shown the potential to help symptoms of depression in patients with rheumatoid arthritis.
In an interview with Christine Moutier, MD, psychiatrist and chief medical officer of the American Foundation for Suicide Prevention, she speaks about how the current COVID-19 pandemic presents opportunities to improve suicide prevention efforts on multiple levels.
Smoking increases the metabolism of clonidine through the CYP1A2, which may require the dose to be doubled to have the same plasma concentration as a non-smoker.
Natalia Skritskaya, PhD, Clinical Psychologist and Research Scientist at the Center for Complicated Grief, Columbia School of Social Work in New York gives her take on the subject of complicated grief.
Adolescents’ psychological challenges are increasingly entangled with their experiences online and virtual interactions with their peers on social media. We look at what this means during the COVID-19 pandemic.
Although the cause of Alzheimer disease is not clear, recent advances in research have furthered the understanding of Alzheimer dementia as a continuum.
An interdisciplinary panel formulated recommendations on opioid tapering strategies in primary care, with particular emphasis placed on addressing biopsychosocial perspectives.
After a decades-long global stop of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding some positive results.
COVID-19 has caused disruptions all across the world. In this piece, we take a look at what working during the pandemic has been like for psychiatric residents, as well as opportunities that the current situation has offered for learning.
This review examines the nerurobiological mechanisms, risk factors, conceptual models, clinical challenges and management for individuals with antidepressant associated hypomania. Greater clarity is required regarding underlying biological mechanisms and the best treatment approaches to assist with clinical decision-making.
Since publication of the last full practice guideline and guideline watch on schizophrenia, there have been a multitude of studies on new pharmacological and nonpharmacological treatments for schizophrenia.
This systematic review further explores whether alterations of the HPA axis that are commonly found in patients with major depressive disorder are due to early life stress or whether the alterations are caused by the MDD itself.
